Bruker (BRKRP) Common Equity (2016 - 2025)
Bruker's Common Equity history spans 17 years, with the latest figure at $2.5 billion for Q4 2025.
- For Q4 2025, Common Equity rose 37.91% year-over-year to $2.5 billion; the TTM value through Dec 2025 reached $2.5 billion, up 37.91%, while the annual FY2025 figure was $2.5 billion, 37.91% up from the prior year.
- Common Equity reached $2.5 billion in Q4 2025 per BRKRP's latest filing, up from $2.4 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $2.5 billion in Q4 2025 to a low of $948.0 million in Q3 2022.
- Average Common Equity over 5 years is $1.4 billion, with a median of $1.2 billion recorded in 2023.
- Peak YoY movement for Common Equity: decreased 13.0% in 2022, then soared 48.73% in 2024.
- A 5-year view of Common Equity shows it stood at $1.1 billion in 2021, then increased by 3.79% to $1.1 billion in 2022, then rose by 23.89% to $1.4 billion in 2023, then grew by 27.72% to $1.8 billion in 2024, then soared by 37.91% to $2.5 billion in 2025.
- Per Business Quant, the three most recent readings for BRKRP's Common Equity are $2.5 billion (Q4 2025), $2.4 billion (Q3 2025), and $1.8 billion (Q2 2025).